CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Vertex wins Overweight at Morgan Stanley as coverage resumes after Crinetics buyout

Positive
AI Analysis

Summary

Morgan Stanley resumes coverage of Vertex Pharmaceuticals with an Overweight rating following Vertex's acquisition of Crinetics Pharmaceuticals.

Importance:4/10
Sentiment:
0.60
analyst_coveragerating_upgradeacquisitionCrinetics
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on September 2, 2026 5:53 PM

Read Original